Streetbeat News

CLVR

Clever Leaves Holdings Inc

cleverleaves.com

Employees

280

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

clever leaves, a colombian company fully-licensed, will become the world’s largest grower with over 10mm+ ft2 of cultivation capacity by 2023, the largest extractor with pharmaceutical grade and gmp certified processing facilities, and the lowest cost operator in cannabis exports. one of the first colombian license holders in the medical cannabis industry. a company positioned to become a leader in the global market with a differentiated business model and strong positioning with regulators, physicians, and other relevant players. developing key capabilities to win in the new space of the medical cannabis industry with a highly experienced and respected team.

Open

1.00

Mkt cap

175

Volume

100

High

1.00

P/E Ratio

N/A

52-wk high

5.89

Low

0.00

Div yield

N/A

52-wk low

0.00

U.S. stocks traded higher with the Dow Jones gaining over 100 points. Domino's Pizza Inc reported better-than-expected Q1 earnings with a 6% sales growth and EPS of $3.58, surpassing estimates. Deciphera Pharmaceuticals announced its acquisition by ONO Pharmaceutical, and Koninklijke Philips N.V. reported a $1.1 billion settlement and better than expected earnings. Clever Leaves Holdings announced plans to delist from Nasdaq, and Addex Therapeutics' epilepsy study failed to meet its primary endpoint.

Portfolio Pulse from Avi Kapoor

April 29, 2024 | 1:42 pm

Clever Leaves Holdings announced its decision to voluntarily delist its common shares from the Nasdaq and deregister its Securities, aiming to terminate and suspend its reporting obligations. This move has led to a decrease in the trading price of its shares.

Portfolio Pulse from Benzinga Newsdesk

April 29, 2024 | 11:27 am

Koninklijke Philips N.V. (PHG) shares surged 37.1% in pre-market trading after announcing Q1 results and a $1.1 billion settlement in the US. Other stocks showed significant movement, with Inno Holdings, Ryde Group, and Akanda Corp among the top gainers. Conversely, Bakkt Holdings and Clever Leaves led the pre-market losers following a reverse stock split and delisting announcement, respectively. Tesla also gained attention with a 7.3% increase after announcing layoffs and a price hike for its Model 3 Performance.

Portfolio Pulse from Avi Kapoor

April 29, 2024 | 9:53 am

Trading for CLVR was halted and then resumed at 4:35:00 PM ET, with updates on news and resumption times provided.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 8:35 pm

Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW) announced its decision to voluntarily delist its common shares and warrants from Nasdaq and deregister its Securities, aiming to terminate and suspend its reporting obligations under the Securities and Exchange Act of 1934. The delisting and deregistration are scheduled for May 2024, with the company citing non-compliance with Nasdaq's listing requirements, high operating expenses, and regulatory burdens as reasons for the decision.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 8:13 pm

Trading for CLVR was halted at 4:06:44 p.m. ET due to pending news. The halt is a temporary measure until the news affecting the company is released.

Portfolio Pulse from Benzinga Newsdesk

April 26, 2024 | 8:06 pm

Clever Leaves Holdings Inc. (NASDAQ:CLVR) (NASDAQ:CLVRW) reported a 6% revenue increase for the full year ended December 31, 2023, with a notable 39% rise in cannabinoid revenue. The fourth quarter saw a 5% revenue increase to $4.6 million, driven by the cannabinoid segment's 29% growth. Operational improvements included a significant increase in harvest volume. The company also completed the sale of its Non-Cannabinoid Herbal Brands Business for $8.02 million on March 21, 2024, as part of its strategic focus on core operations.

Portfolio Pulse from Nicolás Jose Rodriguez

April 02, 2024 | 1:24 am

Clever Leaves Holdings (CLVR) reported a Q4 EPS of $(2.95) and sales of $4.64M, missing the analyst consensus estimate of $5.80M by 20.03%. This represents a slight increase of 0.52% over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 8:03 pm

Tilray and Curaleaf are expanding their presence in Europe, capitalizing on the rapidly growing cannabis market. Curaleaf announced a new supply agreement in the Czech Republic, while Tilray received approval for its first medical cannabis extract in Portugal. The European cannabis market surpassed €2 billion in 2023, with Germany, Czech Republic, Switzerland, and the Netherlands leading regulatory developments. The Benzinga Cannabis Capital Conference in Florida will further discuss these market dynamics.

Portfolio Pulse from Jelena Martinovic

March 14, 2024 | 2:58 pm

Clever Leaves Holdings Inc. partners with Paradise Seeds to develop cannabis cultivars in Colombia, aiming to expand its global footprint. Avicanna Inc. receives approval for Trunerox to treat epilepsy in Colombia, marking a significant milestone. However, Colombian Congress shelved a bill for regulating adult cannabis use, reflecting legislative divisions. This regulatory landscape impacts companies like Clever Leaves, PharmaCielo Ltd, and Khiron Life Sciences Corp, as they navigate the evolving market.

Portfolio Pulse from Nicolás Jose Rodriguez

February 14, 2024 | 4:21 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.